Skip to main content

Home/ TOK Friends/ Group items tagged virus

Rss Feed Group items tagged

Javier E

Five months on, what scientists now know about the coronavirus | World news | The Guardian - 0 views

  • The Sars-CoV-2 virus almost certainly originated in bats, which have evolved fierce immune responses to viruses, researchers have discovered. These defences drive viruses to replicate faster so that they can get past bats’ immune defences. In turn, that transforms the bat into a reservoir of rapidly reproducing and highly transmissible viruses
  • “This virus probably jumped from a bat into another animal, and that other animal was probably near a human, maybe in a market,
  • Virus-ridden particles are inhaled by others and come into contact with cells lining the throat and larynx. These cells have large numbers of receptors – known as Ace-2 receptors – on their surfaces. (Cell receptors play a key role in passing chemicals into cells and in triggering signals between cells.
  • ...19 more annotations...
  • “This virus has a surface protein that is primed to lock on that receptor and slip its RNA into the cell,”
  • Once inside, that RNA inserts itself into the cell’s own replication machinery and makes multiple copies of the virus. These burst out of the cell, and the infection spreads. Antibodies generated by the body’s immune system eventually target the virus and in most cases halt its progress.
  • “A Covid-19 infection is generally mild, and that really is the secret of the virus’s success,” adds Ball. “Many people don’t even notice they have got an infection and so go around their work, homes and supermarkets infecting others.”
  • the virus can cause severe problems. This happens when it moves down the respiratory tract and infects the lungs, which are even richer in cells with Ace-2 receptors. Many of these cells are destroyed, and lungs become congested with bits of broken cell. In these cases, patients will require treatment in intensive care.
  • Even worse, in some cases, a person’s immune system goes into overdrive, attracting cells to the lungs in order to attack the virus, resulting in inflammation
  • This process can run out of control, more immune cells pour in, and the inflammation gets worse. This is known as a cytokine storm.
  • Just why cytokine storms occur in some patients but not in the vast majority is unclear
  • Doctors examining patients recovering from a Covid-19 infection are finding fairly high levels of neutralising antibodies in their blood. These antibodies are made by the immune system, and they coat an invading virus at specific points, blocking its ability to break into cells.
  • Instead, most virologists believe that immunity against Covid-19 will last only a year or two. “That is in line with other coronaviruses that infect humans,
  • “It is clear that immune responses are being mounted against Covid-19 in infected people,” says virologist Mike Skinner of Imperial College London. “And the antibodies created by that response will provide protection against future infections – but we should note that it is unlikely this protection will be for life.”
  • “That means that even if most people do eventually become exposed to the virus, it is still likely to become endemic – which means we would see seasonal peaks of infection of this disease. We will have reached a steady state with regard to Covid-19.”
  • Skinner is doubtful. “We have got to consider this pandemic from the virus’s position,” he says. “It is spreading round the world very nicely. It is doing OK. Change brings it no benefit.”
  • In the end, it will be the development and roll-out of an effective vaccine that will free us from the threat of Covid-19,
  • the journal Nature reported that 78 vaccine projects had been launched round the globe – with a further 37 in development.
  • vaccines require large-scale safety and efficacy studies. Thousands of people would receive either the vaccine itself or a placebo to determine if the former were effective at preventing infection from the virus which they would have encountered naturally. That, inevitably, is a lengthy process.
  • some scientists have proposed a way to speed up the process – by deliberately exposing volunteers to the virus to determine a vaccine’s efficacy.
  • Volunteers would have to be young and healthy, he stresses: “Their health would also be closely monitored, and they would have access to intensive care and any available medicines.”
  • The result could be a vaccine that would save millions of lives by being ready for use in a much shorter time than one that went through standard phase three trials.
  • phase-three trials are still some way off, so we have time to consider the idea carefully.”
Javier E

The Disease Detective - The New York Times - 1 views

  • What’s startling is how many mystery infections still exist today.
  • More than a third of acute respiratory illnesses are idiopathic; the same is true for up to 40 percent of gastrointestinal disorders and more than half the cases of encephalitis (swelling of the brain).
  • Up to 20 percent of cancers and a substantial portion of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis, are thought to have viral triggers, but a vast majority of those have yet to be identified.
  • ...34 more annotations...
  • Globally, the numbers can be even worse, and the stakes often higher. “Say a person comes into the hospital in Sierra Leone with a fever and flulike symptoms,” DeRisi says. “After a few days, or a week, they die. What caused that illness? Most of the time, we never find out. Because if the cause isn’t something that we can culture and test for” — like hepatitis, or strep throat — “it basically just stays a mystery.”
  • It would be better, DeRisi says, to watch for rare cases of mystery illnesses in people, which often exist well before a pathogen gains traction and is able to spread.
  • Based on a retrospective analysis of blood samples, scientists now know that H.I.V. emerged nearly a dozen times over a century, starting in the 1920s, before it went global.
  • Zika was a relatively harmless illness before a single mutation, in 2013, gave the virus the ability to enter and damage brain cells.
  • The beauty of this approach” — running blood samples from people hospitalized all over the world through his system, known as IDseq — “is that it works even for things that we’ve never seen before, or things that we might think we’ve seen but which are actually something new.”
  • In this scenario, an undiscovered or completely new virus won’t trigger a match but will instead be flagged. (Even in those cases, the mystery pathogen will usually belong to a known virus family: coronaviruses, for instance, or filoviruses that cause hemorrhagic fevers like Ebola and Marburg.)
  • And because different types of bacteria require specific conditions in order to grow, you also need some idea of what you’re looking for in order to find it.
  • The same is true of genomic sequencing, which relies on “primers” designed to match different combinations of nucleotides (the building blocks of DNA and RNA).
  • Even looking at a slide under a microscope requires staining, which makes organisms easier to see — but the stains used to identify bacteria and parasites, for instance, aren’t the same.
  • The practice that DeRisi helped pioneer to skirt this problem is known as metagenomic sequencing
  • Unlike ordinary genomic sequencing, which tries to spell out the purified DNA of a single, known organism, metagenomic sequencing can be applied to a messy sample of just about anything — blood, mud, seawater, snot — which will often contain dozens or hundreds of different organisms, all unknown, and each with its own DNA. In order to read all the fragmented genetic material, metagenomic sequencing uses sophisticated software to stitch the pieces together by matching overlapping segments.
  • The assembled genomes are then compared against a vast database of all known genomic sequences — maintained by the government-run National Center for Biotechnology Information — making it possible for researchers to identify everything in the mix
  • Traditionally, the way that scientists have identified organisms in a sample is to culture them: Isolate a particular bacterium (or virus or parasite or fungus); grow it in a petri dish; and then examine the result under a microscope, or use genomic sequencing, to understand just what it is. But because less than 2 percent of bacteria — and even fewer viruses — can be grown in a lab, the process often reveals only a tiny fraction of what’s actually there. It’s a bit like planting 100 different kinds of seeds that you found in an old jar. One or two of those will germinate and produce a plant, but there’s no way to know what the rest might have grown into.
  • Such studies have revealed just how vast the microbial world is, and how little we know about it
  • “The selling point for researchers is: ‘Look, this technology lets you investigate what’s happening in your clinic, whether it’s kids with meningitis or something else,’” DeRisi said. “We’re not telling you what to do with it. But it’s also true that if we have enough people using this, spread out all around the world, then it does become a global network for detecting emerging pandemics
  • One study found more than 1,000 different kinds of viruses in a tiny amount of human stool; another found a million in a couple of pounds of marine sediment. And most were organisms that nobody had seen before.
  • After the Biohub opened in 2016, one of DeRisi’s goals was to turn metagenomics from a rarefied technology used by a handful of elite universities into something that researchers around the world could benefit from
  • metagenomics requires enormous amounts of computing power, putting it out of reach of all but the most well-funded research labs. The tool DeRisi created, IDseq, made it possible for researchers anywhere in the world to process samples through the use of a small, off-the-shelf sequencer, much like the one DeRisi had shown me in his lab, and then upload the results to the cloud for analysis.
  • he’s the first to make the process so accessible, even in countries where lab supplies and training are scarce. DeRisi and his team tested the chemicals used to prepare DNA for sequencing and determined that using as little as half the recommended amount often worked fine. They also 3-D print some of the labs’ tools and replacement parts, and offer ongoing training and tech support
  • The metagenomic analysis itself — normally the most expensive part of the process — is provided free.
  • But DeRisi’s main innovation has been in streamlining and simplifying the extraordinarily complex computational side of metagenomics
  • IDseq is also fast, capable of doing analyses in hours that would take other systems weeks.
  • “What IDseq really did was to marry wet-lab work — accumulating samples, processing them, running them through a sequencer — with the bioinformatic analysis,”
  • “Without that, what happens in a lot of places is that the researcher will be like, ‘OK, I collected the samples!’ But because they can’t analyze them, the samples end up in the freezer. The information just gets stuck there.”
  • Meningitis itself isn’t a disease, just a description meaning that the tissues around the brain and spinal cord have become inflamed. In the United States, bacterial infections can cause meningitis, as can enteroviruses, mumps and herpes simplex. But a high proportion of cases have, as doctors say, no known etiology: No one knows why the patient’s brain and spinal tissues are swelling.
  • When Saha and her team ran the mystery meningitis samples through IDseq, though, the result was surprising. Rather than revealing a bacterial cause, as expected, a third of the samples showed signs of the chikungunya virus — specifically, a neuroinvasive strain that was thought to be extremely rare. “At first we thought, It cannot be true!” Saha recalls. “But the moment Joe and I realized it was chikungunya, I went back and looked at the other 200 samples that we had collected around the same time. And we found the virus in some of those samples as well.”
  • Until recently, chikungunya was a comparatively rare disease, present mostly in parts of Central and East Africa. “Then it just exploded through the Caribbean and Africa and across Southeast Asia into India and Bangladesh,” DeRisi told me. In 2011, there were zero cases of chikungunya reported in Latin America. By 2014, there were a million.
  • Chikungunya is a mosquito-borne virus, but when DeRisi and Saha looked at the results from IDseq, they also saw something else: a primate tetraparvovirus. Primate tetraparvoviruses are almost unknown in humans, and have been found only in certain regions. Even now, DeRisi is careful to note, it’s not clear what effect the virus has on people. “Maybe it’s dangerous, maybe it isn’t,” DeRisi says. “But I’ll tell you what: It’s now on my radar.
  • it reveals a landscape of potentially dangerous viruses that we would otherwise never find out about. “What we’ve been missing is that there’s an entire universe of pathogens out there that are causing disease in humans,” Imam notes, “ones that we often don’t even know exist.”
  • “The plan was, Let’s let researchers around the world propose studies, and we’ll choose 10 of them to start,” DeRisi recalls. “We thought we’d get, like, a couple dozen proposals, and instead we got 350.”
  • Metagenomic sequencing is especially good at what scientists call “environmental sampling”: identifying, say, every type of bacteria present in the gut microbiome, or in a teaspoon of seawater.
  • “When you draw blood from someone who has a fever in Ghana, you really don’t know very much about what would normally be in their blood without fever — let alone about other kinds of contaminants in the environment. So how do you interpret the relevance of all the things you’re seeing?”
  • Such criticisms have led some to say that metagenomics simply isn’t suited to the infrastructure of developing countries. Along with the problem of contamination, many labs struggle to get the chemical reagents needed for sequencing, either because of the cost or because of shipping and customs holdups
  • we’re less likely to be caught off-guard. “With Ebola, there’s always an issue: Where’s the virus hiding before it breaks out?” DeRisi explains. “But also, once we start sampling people who are hospitalized more widely — meaning not just people in Northern California or Boston, but in Uganda, and Sierra Leone, and Indonesia — the chance of disastrous surprises will go down. We’ll start seeing what’s hidden.”
Javier E

If We Knew Then What We Know Now About Covid, What Would We Have Done Differently? - WSJ - 0 views

  • For much of 2020, doctors and public-health officials thought the virus was transmitted through droplets emitted from one person’s mouth and touched or inhaled by another person nearby. We were advised to stay at least 6 feet away from each other to avoid the droplets
  • A small cadre of aerosol scientists had a different theory. They suspected that Covid-19 was transmitted not so much by droplets but by smaller infectious aerosol particles that could travel on air currents way farther than 6 feet and linger in the air for hours. Some of the aerosol particles, they believed, were small enough to penetrate the cloth masks widely used at the time.
  • The group had a hard time getting public-health officials to embrace their theory. For one thing, many of them were engineers, not doctors.
  • ...37 more annotations...
  • “My first and biggest wish is that we had known early that Covid-19 was airborne,”
  • , “Once you’ve realized that, it informs an entirely different strategy for protection.” Masking, ventilation and air cleaning become key, as well as avoiding high-risk encounters with strangers, he says.
  • Instead of washing our produce and wearing hand-sewn cloth masks, we could have made sure to avoid superspreader events and worn more-effective N95 masks or their equivalent. “We could have made more of an effort to develop and distribute N95s to everyone,” says Dr. Volckens. “We could have had an Operation Warp Speed for masks.”
  • We didn’t realize how important clear, straight talk would be to maintaining public trust. If we had, we could have explained the biological nature of a virus and warned that Covid-19 would change in unpredictable ways.  
  • We didn’t know how difficult it would be to get the basic data needed to make good public-health and medical decisions. If we’d had the data, we could have more effectively allocated scarce resources
  • In the face of a pandemic, he says, the public needs an early basic and blunt lesson in virology
  • and mutates, and since we’ve never seen this particular virus before, we will need to take unprecedented actions and we will make mistakes, he says.
  • Since the public wasn’t prepared, “people weren’t able to pivot when the knowledge changed,”
  • By the time the vaccines became available, public trust had been eroded by myriad contradictory messages—about the usefulness of masks, the ways in which the virus could be spread, and whether the virus would have an end date.
  • , the absence of a single, trusted source of clear information meant that many people gave up on trying to stay current or dismissed the different points of advice as partisan and untrustworthy.
  • “The science is really important, but if you don’t get the trust and communication right, it can only take you so far,”
  • people didn’t know whether it was OK to visit elderly relatives or go to a dinner party.
  • Doctors didn’t know what medicines worked. Governors and mayors didn’t have the information they needed to know whether to require masks. School officials lacked the information needed to know whether it was safe to open schools.
  • Had we known that even a mild case of Covid-19 could result in long Covid and other serious chronic health problems, we might have calculated our own personal risk differently and taken more care.
  • just months before the outbreak of the pandemic, the Council of State and Territorial Epidemiologists released a white paper detailing the urgent need to modernize the nation’s public-health system still reliant on manual data collection methods—paper records, phone calls, spreadsheets and faxes.
  • While the U.K. and Israel were collecting and disseminating Covid case data promptly, in the U.S. the CDC couldn’t. It didn’t have a centralized health-data collection system like those countries did, but rather relied on voluntary reporting by underfunded state and local public-health systems and hospitals.
  • doctors and scientists say they had to depend on information from Israel, the U.K. and South Africa to understand the nature of new variants and the effectiveness of treatments and vaccines. They relied heavily on private data collection efforts such as a dashboard at Johns Hopkins University’s Coronavirus Resource Center that tallied cases, deaths and vaccine rates globally.
  • For much of the pandemic, doctors, epidemiologists, and state and local governments had no way to find out in real time how many people were contracting Covid-19, getting hospitalized and dying
  • To solve the data problem, Dr. Ranney says, we need to build a public-health system that can collect and disseminate data and acts like an electrical grid. The power company sees a storm coming and lines up repair crews.
  • If we’d known how damaging lockdowns would be to mental health, physical health and the economy, we could have taken a more strategic approach to closing businesses and keeping people at home.
  • t many doctors say they were crucial at the start of the pandemic to give doctors and hospitals a chance to figure out how to accommodate and treat the avalanche of very sick patients.
  • The measures reduced deaths, according to many studies—but at a steep cost.
  • The lockdowns didn’t have to be so harmful, some scientists say. They could have been more carefully tailored to protect the most vulnerable, such as those in nursing homes and retirement communities, and to minimize widespread disruption.
  • Lockdowns could, during Covid-19 surges, close places such as bars and restaurants where the virus is most likely to spread, while allowing other businesses to stay open with safety precautions like masking and ventilation in place.  
  • The key isn’t to have the lockdowns last a long time, but that they are deployed earlier,
  • If England’s March 23, 2020, lockdown had begun one week earlier, the measure would have nearly halved the estimated 48,600 deaths in the first wave of England’s pandemic
  • If the lockdown had begun a week later, deaths in the same period would have more than doubled
  • It is possible to avoid lockdowns altogether. Taiwan, South Korea and Hong Kong—all countries experienced at handling disease outbreaks such as SARS in 2003 and MERS—avoided lockdowns by widespread masking, tracking the spread of the virus through testing and contact tracing and quarantining infected individuals.
  • With good data, Dr. Ranney says, she could have better managed staffing and taken steps to alleviate the strain on doctors and nurses by arranging child care for them.
  • Early in the pandemic, public-health officials were clear: The people at increased risk for severe Covid-19 illness were older, immunocompromised, had chronic kidney disease, Type 2 diabetes or serious heart conditions
  • t had the unfortunate effect of giving a false sense of security to people who weren’t in those high-risk categories. Once case rates dropped, vaccines became available and fear of the virus wore off, many people let their guard down, ditching masks, spending time in crowded indoor places.
  • it has become clear that even people with mild cases of Covid-19 can develop long-term serious and debilitating diseases. Long Covid, whose symptoms include months of persistent fatigue, shortness of breath, muscle aches and brain fog, hasn’t been the virus’s only nasty surprise
  • In February 2022, a study found that, for at least a year, people who had Covid-19 had a substantially increased risk of heart disease—even people who were younger and had not been hospitalized
  • respiratory conditions.
  • Some scientists now suspect that Covid-19 might be capable of affecting nearly every organ system in the body. It may play a role in the activation of dormant viruses and latent autoimmune conditions people didn’t know they had
  •  A blood test, he says, would tell people if they are at higher risk of long Covid and whether they should have antivirals on hand to take right away should they contract Covid-19.
  • If the risks of long Covid had been known, would people have reacted differently, especially given the confusion over masks and lockdowns and variants? Perhaps. At the least, many people might not have assumed they were out of the woods just because they didn’t have any of the risk factors.
Javier E

What Does Coronavirus Do to the Body? - The New York Times - 0 views

  • the virus appears to start in peripheral areas on both sides of the lung and can take a while to reach the upper respiratory tract, the trachea and other central airways.
  • that pattern helps explain why in Wuhan, where the outbreak began, many of the earliest cases were not identified immediately.
  • The initial testing regimen in many Chinese hospitals did not always detect infection in the peripheral lungs, so some people with symptoms were sent home without treatment.
  • ...18 more annotations...
  • it’s unclear whether infectious virus can persist in blood or stool
  • the infection can spread through the mucous membranes, from the nose down to the rectum.
  • while the virus appears to zero in on the lungs, it may also be able to infect cells in the gastrointestinal system, experts say. This may be why some patients have symptoms like diarrhea or indigestion
  • “The virus will actually land on organs like the heart, the kidney, the liver, and may cause some direct damage to those organs,
  • some patients in China recovered but got sick again, apparently because they had damaged and vulnerable lung tissue that was subsequently attacked by bacteria in their body.
  • As the body’s immune system shifts into high gear to battle the infection, the resulting inflammation may cause those organs to malfunction, he said.
  • About 80 percent of people infected with the new coronavirus have relatively mild symptoms. But about 20 percent of people become more seriously ill and in about 2 percent of patients in China, which has had the most cases, the disease has been fatal.
  • the effects appear to depend on how robust or weakened a person’s immune system is. Older people or those with underlying health issues, like diabetes or another chronic illness, are more likely to develop severe symptoms
  • the course a patient’s coronavirus will take is not yet fully understood.
  • Some patients can remain stable for over a week and then suddenly develop pneumonia, Dr. Diaz said. Some patients seem to recover but then develop symptoms again.
  • more than half of 121 patients in China had normal CT scans early in their disease.
  • Coronavirus particles have spiked proteins sticking out from their surfaces, and these spikes hook onto cell membranes, allowing the virus’s genetic material to enter the human cell.
  • That genetic material proceeds to “hijack the metabolism of the cell and say, in effect, ‘Don’t do your usual job. Your job now is to help me multiply and make the virus,’
  • As copies of the virus multiply, they burst out and infect neighboring cells. The symptoms often start in the back of the throat with a sore throat and a dry cough.
  • The virus then “crawls progressively down the bronchial tubes,”
  • That can damage the alveoli or lung sacs and they have to work harder to carry out their function of supplying oxygen to the blood
  • The swelling and the impaired flow of oxygen can cause those areas in the lungs to fill with fluid, pus and dead cells. Pneumonia, an infection in the lung, can occur
  • Some people have so much trouble breathing they need to be put on a ventilator
katherineharron

Spain coronavirus: How nation became one of world's pandemic hotspots - CNN - 0 views

  • Unseasonably warm weather, Champions League football and other major events, homes on the beach and the café culture: just a few of the factors that may have helped carry an insidious virus across southern Europe -- from country to country and city to city, from Italy to Spain and Portugal.
  • More than 5,000 people have died since a coronavirus outbreak exploded in Spain, one of the countries worst affected by the pandemic. The country has more than 54,000 active cases of the virus, according to recent figures from the ministry of health.
  • Immunologist Francesco Le Foche is of the same view, telling the Corriere dello Sport: "It's probable that there were several major triggers and catalysts for the diffusion of the virus, but the Atalanta-Valencia game could very well have been one of them.
  • ...2 more annotations...
  • Two days later, in the town of Codogno, some 60 kilometers (40 miles) from Bergamo, a 38-year-old man known as "patient one" was diagnosed with the virus. But by then, according to research reported by nearly 20 Italian specialists, the virus had long been on the move.
  • But in other respects, life in Spain went on pretty much as normal. Bars and cafes were open; unseasonably warm weather brought Spaniards out into common spaces. Rallies for International Women's Day on March 8 brought tens of thousands onto the streets across Spain, including a crowd estimated at 120,000 in Madrid. Two female cabinet ministers who attended the event later tested positive for coronavirus, although it's not known how they contracted the virus. Opposition parties have criticized the government for allowing those events to go ahead.
Javier E

How the leading coronavirus vaccines made it to the finish line - The Washington Post - 0 views

  • If, as expected in the next few weeks, regulators give those vaccines the green light, the technology and the precision approach to vaccine design could turn out to be the pandemic’s silver linings: scientific breakthroughs that could begin to change the trajectory of the virus this winter and also pave the way for highly effective vaccines and treatments for other diseases.
  • Vaccine development typically takes years, even decades. The progress of the last 11 months shifts the paradigm for what’s possible, creating a new model for vaccine development and a toolset for a world that will have to fight more never-before-seen viruses in years to come.
  • Long before the pandemic, Graham worked with colleagues there and in academia to create a particularly accurate 3-D version of the spiky proteins that protrude from the surface of coronaviruses — an innovation that was rejected for publication by scientific journals five times because reviewers questioned its relevance.
  • ...26 more annotations...
  • Messenger RNA is a powerful, if fickle, component of life’s building blocks — a workhorse of the cell that is also truly just a messenger, unstable and prone to degrade.
  • . In 1990,
  • That same year, a team at the University of Wisconsin startled the scientific world with a paper that showed it was possible to inject a snippet of messenger RNA into mice and turn their muscle cells into factories, creating proteins on demand.
  • If custom-designed RNA snippets could be used to turn cells into bespoke protein factories, messenger RNA could become a powerful medical tool. It could encode fragments of virus to teach the immune system to defend against pathogens. It could also create whole proteins that are missing or damaged in people with devastating genetic diseases, such as cystic fibrosis.
  • In 2005, the pair discovered a way to modify RNA, chemically tweaking one of the letters of its code, so it didn’t trigger an inflammatory response. Deborah Fuller, a scientist who works on RNA and DNA vaccines at the University of Washington, said that work deserves a Nobel Prize.
  • messenger RNA posed a bigger challenge than other targets.“It’s tougher — it’s a much bigger molecule, it’s much more unstable,”
  • Unlike fields that were sparked by a single powerful insight, Sahin said that the recent success of messenger RNA vaccines is a story of countless improvements that turned an alluring biological idea into a beneficial technology.
  • “This is a field which benefited from hundreds of inventions,” said Sahin, who noted that when he started BioNTech in 2008, he cautioned investors that the technology would not yield a product for at least a decade. He kept his word: Until the coronavirus sped things along, BioNTech projected the launch of its first commercial project in 2023.
  • “It’s new to you,” Fuller said. “But for basic researchers, it’s been long enough. . . . Even before covid, everyone was talking: RNA, RNA, RNA.”
  • All vaccines are based on the same underlying idea: training the immune system to block a virus. Old-fashioned vaccines do this work by injecting dead or weakened viruses
  • ewer vaccines use distinctive bits of the virus, such as proteins on their surface, to teach the lesson. The latest genetic techniques, like messenger RNA, don’t take as long to develop because those virus bits don’t have to be generated in a lab. Instead, the vaccine delivers a genetic code that instructs cells to build those characteristic proteins themselves.
  • They wanted the immune system to learn to recognize the thumb tack spike, so McLellan tasked a scientist in his laboratory with identifying genetic mutations that could anchor the protein into the right configuration. It was a painstaking process for Nianshuang Wang, who now works at a biotechnology company, Regeneron Pharmaceuticals. After trying hundreds of genetic mutations, he found two that worked. Five journals rejected the finding, questioning its significance, before it was published in 2017.
  • That infection opened Graham’s eyes to an opportunity. HKU1 was merely a nuisance, as opposed to a deadly pneumonia; that meant it would be easier to work with in the lab, since researchers wouldn’t have to don layers of protective gear and work in a pressurized laboratory.
  • Severe acute respiratory syndrome had emerged in 2003. Middle East respiratory syndrome (MERS) broke out in 2012. It seemed clear to Graham and Jason McLellan, a structural biologist now at the University of Texas at Austin, that new coronaviruses were jumping into people on a 10-year-clock and it might be time to brace for the next one.
  • Last winter, when Graham heard rumblings of a new coronavirus in China, he brought the team back together. Once its genome was shared online by Chinese scientists, the laboratories in Texas and Maryland designed a vaccine, utilizing the stabilizing mutations and the knowledge they had gained from years of basic research — a weekend project thanks to the dividends of all that past work.
  • Graham needed a technology that could deliver it into the body — and had already been working with Moderna, using its messenger RNA technology to create a vaccine against a different bat virus, Nipah, as a dress rehearsal for a real pandemic. Moderna and NIH set the Nipah project aside and decided to go forward with a coronavirus vaccine.
  • On Jan. 13, Moderna’s Moore came into work and found her team already busy translating the stabilized spike protein into their platform. The company could start making the vaccine almost right away because of its experience manufacturing experimental cancer vaccines, which involves taking tumor samples and developing personalized vaccines in 45 days.
  • At BioNTech, Sahin said that even in the early design phases of its vaccine candidates, he incorporated the slight genetic changes designed in Graham’s lab that would make the spike look more like the real thing. At least two other companies would incorporate that same spike.
  • If all goes well with regulators, the coronavirus vaccines have the makings of a pharmaceutical industry fairy tale. The world faced an unparalleled threat, and companies leaped into the fight. Pfizer plowed $2 billion into the effort. Massive infusions of government cash helped remove the financial risks for Moderna.
  • But the world will also owe their existence to many scientists outside those companies, in government and academia who pursued ideas they thought were important even when the world doubted them
  • Some of those scientists will receive remuneration, since their inventions are licensed and integrated into the products that could save the world.
  • As executives become billionaires, many scientists think it is fair to earn money from their inventions that can help them do more important work. But McLellan’s laboratory at the University of Texas is proud to have licensed an even more potent version of their spike protein, royalty-free, to be incorporated into a vaccine for low and middle income countries.
  • “They’re using the technology that [Kariko] and I developed,” he said. “We feel like it’s our vaccine, and we are incredibly excited — at how well it’s going, and how it’s going to be used to get rid of this pandemic.”
  • “People hear about [vaccine progress] and think someone just thought about it that night. The amount of work — it’s really a beautiful story of fundamental basic research,” Fauci said. “It was chancy, in the sense that [the vaccine technology] was new. We were aware there would be pushback. The proof in the pudding is a spectacular success.”
  • The Vaccine Research Center, where Graham is deputy director, was the brainchild of Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. It was created in 1997 to bring together scientists and physicians from different disciplines to defeat diseases, with a heavy focus on HIV.
  • the pandemic wasn’t a sudden eureka moment — it was a catalyst that helped ignite lines of research that had been moving forward for years, far outside the spotlight of a global crisis.
Javier E

Covid-19 pandemic and chaos theory: Why the future is impossible to precisely predict -... - 0 views

  • In Washington state, a person with the virus attended a choir practice, and more than half of the other singers subsequently got sick. In South Korea, a 29-year-old man went out to nightclubs; he was Covid-19 positive, and he has since been linked to at least 54 new cases. In China, nine people sitting in the path of an air conditioning vent in a restaurant all got sick, most likely from one person, as the duct blew viral particles across their faces.
  • Small things could have changed these outcomes. The clubber could have decided to watch TV instead of going out dancing. If the choir practice was rescheduled for the next day, maybe the person would have felt sick and stayed home. The air conditioner in the restaurant could have been turned off.
  • “Little shifts can have really disproportionately sized impacts” in a pandemic. And scientists have a name for systems that operate like this: chaos.
  • ...16 more annotations...
  • An outbreak isn’t a double pendulum; it’s much more convoluted. Myriad chains of events, operating in overlapping networks, conspire to chart its course.
  • It’s the double pendulum, and as a physical object, it’s very simple: A pendulum (a string and a weight) is attached to the bottom of another. Its movement is explained by the laws of motion written by Isaac Newton hundreds of years ago.
  • But slight changes in the initial condition of the pendulum — say it starts its swing from a little higher up, or if the weight of the pendulum balls is a little heavier, or one of the pendulum arms is a bit longer than the other — lead to wildly different outcomes that are very hard to predict.
  • The double pendulum is chaotic because the motion of the first pendulum influences the motion of the second, which then influences the entire apparatus. There isn’t a simple scale or ratio to describe how the inputs relate to the outputs. A one-gram change to the weight of a pendulum ball can result in a very different swing pattern than a two-gram change.
  • It teaches us to understand the mechanics of a system — the science of how it works — without being able to precisely predict its future. It helps us visualize how something that seems like it should be linear and predictable just isn’t.
  • That’s why, when pressed, epidemiologists have to say they don’t know what’s going to happen.
  • Climate scientists clearly tell us adding CO2 to the air will increase global temperatures. Yet they argue about when the worst effects of climate change will be felt and how bad it will be
  • Still, they know the mechanics of outbreaks. The chaos “doesn’t necessarily mean we know nothing,” Kissler says. They understand the conditions that make an outbreak worse and the conditions that make it better.
  • There is a tough tension of the current moment that we all need to work through: The future is clouded in chaos, but we know the mechanics of this system
  • Here are the mechanics. Scientists know that if we let up on social distancing, without an alternative plan in place, the virus can infect more people. They know this virus is likely to persist for at least a few years without a vaccine. They know it’s very contagious. That it’s very deadly. They also know that its pandemic potential is hardly spent, and that most of the population of the United States and the world is still vulnerable to it.
  • Will residents keep up with mask-wearing and social distancing, even when their leaders relax regulations? Plus, there are scientific questions about the virus still not understood: Will it diminish transmission in a seasonal pattern? Do children contribute greatly to its spread? How long does immunity last after an infection? Why do some people breathe out more of the virus than others? The answers to these questions will influence the future, and we do not know the answers.
  • Scientists are still unraveling what makes the difference between a sprawling outbreak in one city and a more manageable one in another. Some of it is the result of policy, some is the result of demographics, some is about structural inequality and racism, and some comes down to individual behavior. Some of it is just luck. That’s chaos for you.
  • “I don’t see uncertainty as a lack of knowledge,” says Philipp Lorenz-Spreen, a physicist who studies the chaos of a different sort of viral dynamics. “I think it’s a fundamental part of how our world works. It’s not our fault we do not know where this all will go.”
  • Newton clearly told us what happens when an object drops from the sky. But follow his laws, and find that the path of a double pendulum is very, very difficult to predict.
  • There’s a simple mechanism that is helping me understand the many possible futures we face with the Covid-19 pandemic.
  • Epidemiologists are clearly telling us what happens when you bring masses of people together during a pandemic. But they can’t tell us the exact shape this outbreak will take.
Javier E

Opinion | Why Covid's Airborne Transmission Was Acknowledged So Late - The New York Times - 0 views

  • A week ago, more than a year after the World Health Organization declared that we face a pandemic, a page on its website titled “Coronavirus Disease (Covid-19): How Is It Transmitted?” got a seemingly small update.
  • The revised response still emphasizes transmission in close contact but now says it may be via aerosols — smaller respiratory particles that can float — as well as droplets. It also adds a reason the virus can also be transmitted “in poorly ventilated and/or crowded indoor settings,” saying this is because “aerosols remain suspended in the air or travel farther than 1 meter.”
  • on Friday, the Centers for Disease Control and Prevention also updated its guidance on Covid-19, clearly saying that inhalation of these smaller particles is a key way the virus is transmitted, even at close range, and put it on top of its list of how the disease spreads.
  • ...38 more annotations...
  • But these latest shifts challenge key infection control assumptions that go back a century, putting a lot of what went wrong last year in context
  • They may also signal one of the most important advancements in public health during this pandemic.
  • If the importance of aerosol transmission had been accepted early, we would have been told from the beginning that it was much safer outdoors, where these small particles disperse more easily, as long as you avoid close, prolonged contact with others.
  • We would have tried to make sure indoor spaces were well ventilated, with air filtered as necessary.
  • Instead of blanket rules on gatherings, we would have targeted conditions that can produce superspreading events: people in poorly ventilated indoor spaces, especially if engaged over time in activities that increase aerosol production, like shouting and singing
  • We would have started using masks more quickly, and we would have paid more attention to their fit, too. And we would have been less obsessed with cleaning surfaces.
  • The implications of this were illustrated when I visited New York City in late April — my first trip there in more than a year.
  • A giant digital billboard greeted me at Times Square, with the message “Protecting yourself and others from Covid-19. Guidance from the World Health Organization.”
  • That billboard neglected the clearest epidemiological pattern of this pandemic: The vast majority of transmission has been indoors, sometimes beyond a range of three or even six feet. The superspreading events that play a major role in driving the pandemic occur overwhelmingly, if not exclusively, indoors.
  • The billboard had not a word about ventilation, nothing about opening windows or moving activities outdoors, where transmission has been rare and usually only during prolonged and close contact. (Ireland recently reported 0.1 percent of Covid-19 cases were traced to outdoor transmission.)
  • Mary-Louise McLaws, an epidemiologist at the University of New South Wales in Sydney, Australia, and a member of the W.H.O. committees that craft infection prevention and control guidance, wanted all this examined but knew the stakes made it harder to overcome the resistance. She told The Times last year, “If we started revisiting airflow, we would have to be prepared to change a lot of what we do.” She said it was a very good idea, but she added, “It will cause an enormous shudder through the infection control society.”
  • In contrast, if the aerosols had been considered a major form of transmission, in addition to distancing and masks, advice would have centered on ventilation and airflow, as well as time spent indoors. Small particles can accumulate in enclosed spaces, since they can remain suspended in the air and travel along air currents. This means that indoors, three or even six feet, while helpful, is not completely protective, especially over time.
  • To see this misunderstanding in action, look at what’s still happening throughout the world. In India, where hospitals have run out of supplemental oxygen and people are dying in the streets, money is being spent on fleets of drones to spray anti-coronavirus disinfectant in outdoor spaces. Parks, beaches and outdoor areas keep getting closed around the world. This year and last, organizers canceled outdoor events for the National Cherry Blossom Festival in Washington, D.C. Cambodian customs officials advised spraying disinfectant outside vehicles imported from India. The examples are many.
  • Meanwhile, many countries allowed their indoor workplaces to open but with inadequate aerosol protections. There was no attention to ventilation, installing air filters as necessary or even opening windows when possible, more to having people just distancing three or six feet, sometimes not requiring masks beyond that distance, or spending money on hard plastic barriers, which may be useless at best
  • clear evidence doesn’t easily overturn tradition or overcome entrenched feelings and egos. John Snow, often credited as the first scientific epidemiologist, showed that a contaminated well was responsible for a 1854 London cholera epidemic by removing the suspected pump’s handle and documenting how the cases plummeted afterward. Many other scientists and officials wouldn’t believe him for 12 years, when the link to a water source showed up again and became harder to deny.
  • Along the way to modern public health shaped largely by the fight over germs, a theory of transmission promoted by the influential public health figure Charles Chapin took hold
  • Dr. Chapin asserted in the early 1900s that respiratory diseases were most likely spread at close range by people touching bodily fluids or ejecting respiratory droplets, and did not allow for the possibility that such close-range infection could occur by inhaling small floating particles others emitted
  • He was also concerned that belief in airborne transmission, which he associated with miasma theories, would make people feel helpless and drop their guard against contact transmission. This was a mistake that would haunt infection control for the next century and more.
  • It was in this context in early 2020 that the W.H.O. and the C.D.C. asserted that SARS-CoV-2 was transmitted primarily via these heavier, short-range droplets, and provided guidance accordingly
  • Amid the growing evidence, in July, hundreds of scientists signed an open letter urging the public health agencies, especially the W.H.O., to address airborne transmission of the coronavirus.
  • Last October, the C.D.C. published updated guidance acknowledging airborne transmission, but as a secondary route under some circumstances, until it acknowledged airborne transmission as crucial on Friday. And the W.H.O. kept inching forward in its public statements, most recently a week ago.
  • Linsey Marr, a professor of engineering at Virginia Tech who made important contributions to our understanding of airborne virus transmission before the pandemic, pointed to two key scientific errors — rooted in a lot of history — that explain the resistance, and also opened a fascinating sociological window into how science can get it wrong and why.
  • Dr. Marr said that if you inhale a particle from the air, it’s an aerosol.
  • biomechanically, she said, nasal transmission faces obstacles, since nostrils point downward and the physics of particles that large makes it difficult for them to move up the nose. And in lab measurements, people emit far more of the easier-to-inhale aerosols than the droplets, she said, and even the smallest particles can be virus laden, sometimes more so than the larger ones, seemingly because of how and where they are produced in the respiratory tract.
  • Second, she said, proximity is conducive to transmission of aerosols as well because aerosols are more concentrated near the person emitting them. In a twist of history, modern scientists have been acting like those who equated stinky air with disease, by equating close contact, a measure of distance, only with the larger droplets, a mechanism of transmission, without examination.
  • Since aerosols also infect at close range, measures to prevent droplet transmission — masks and distancing — can help dampen transmission for airborne diseases as well. However, this oversight led medical people to circularly assume that if such measures worked at all, droplets must have played a big role in their transmission.
  • Another dynamic we’ve seen is something that is not unheard-of in the history of science: setting a higher standard of proof for theories that challenge conventional wisdom than for those that support it.
  • Another key problem is that, understandably, we find it harder to walk things back. It is easier to keep adding exceptions and justifications to a belief than to admit that a challenger has a better explanation.
  • The ancients believed that all celestial objects revolved around the earth in circular orbits. When it became clear that the observed behavior of the celestial objects did not fit this assumption, those astronomers produced ever-more-complex charts by adding epicycles — intersecting arcs and circles — to fit the heavens to their beliefs.
  • In a contemporary example of this attitude, the initial public health report on the Mount Vernon choir case said that it may have been caused by people “sitting close to one another, sharing snacks and stacking chairs at the end of the practice,” even though almost 90 percent of the people there developed symptoms of Covid-19
  • So much of what we have done throughout the pandemic — the excessive hygiene theater and the failure to integrate ventilation and filters into our basic advice — has greatly hampered our response.
  • Some of it, like the way we underused or even shut down outdoor space, isn’t that different from the 19th-century Londoners who flushed the source of their foul air into the Thames and made the cholera epidemic worse.
  • Righting this ship cannot be a quiet process — updating a web page here, saying the right thing there. The proclamations that we now know are wrong were so persistent and so loud for so long.
  • the progress we’ve made might lead to an overhaul in our understanding of many other transmissible respiratory diseases that take a terrible toll around the world each year and could easily cause other pandemics.
  • So big proclamations require probably even bigger proclamations to correct, or the information void, unnecessary fears and misinformation will persist, damaging the W.H.O. now and in the future.
  • I’ve seen our paper used in India to try to reason through aerosol transmission and the necessary mitigations. I’ve heard of people in India closing their windows after hearing that the virus is airborne, likely because they were not being told how to respond
  • The W.H.O. needs to address these fears and concerns, treating it as a matter of profound change, so other public health agencies and governments, as well as ordinary people, can better adjust.
  • It needs to begin a campaign proportional to the importance of all this, announcing, “We’ve learned more, and here’s what’s changed, and here’s how we can make sure everyone understands how important this is.” That’s what credible leadership looks like. Otherwise, if a web page is updated in the forest without the requisite fanfare, how will it matter?
lucieperloff

How the 'Alpha' Coronavirus Variant Became So Powerful - The New York Times - 0 views

  • British researchers discovered that a new variant was sweeping through their country.
  • tended to become more common in its new homes as well
  • Alpha disables the first line of immune defense in our bodies, giving the variant more time to multiply.
  • ...10 more annotations...
  • . “Any successful virus has to get beyond that first defense system. The more successful it is at doing that, the better off the virus is.”
  • A lot of researchers focused their attention on the nine mutations that alter the so-called spike protein that covers the coronavirus and allows it to invade cells
  • They found that lung cells with Alpha made drastically less interferon, a protein that switches on a host of immune defenses.
  • It’s making itself more invisible,”
  • They found that Alpha-infected cells make a lot of extra copies — some 80 times more than other versions of the virus — of a gene called Orf9b.
  • dampening the production of interferon and a full immune response. The virus, protected from attack, has better odds of making copies of itself.
  • people infected with Alpha have a more robust reaction than they would with other variants, coughing and shedding virus-laden mucus from not only their mouths, but also their noses — making Alpha even better at spreading.
  • . They may have independently evolved their own tricks for manipulating our immune system.
  • But studies on people who recover naturally from Covid-19 have shown that their immune systems learn to recognize other viral proteins, including Orf9b.
  • “It’s quite a tricky enterprise, but becoming more possible as we learn more,”
Javier E

Mutated virus may reinfect people already stricken once with covid-19, sparking debate ... - 0 views

  • it appears a vaccine is better than natural infection in protecting people, calling it “a big, strong plug to get vaccinated” and a reality check for people who may have assumed that because they have already been infected, they are immune.
  • In the placebo group of the trial for Novavax’s vaccine, people with prior coronavirus infections appeared just as likely to get sick as people without them, meaning they weren’t fully protected against the B.1.351 variant that has swiftly become dominant in South Africa.
  • “The data really are quite suggestive: The level of immunity that you get from natural infection — either the degree of immunity, the intensity of the immunity or the breadth of immunity — is obviously not enough to protect against infection with the mutant,” Fauci said.
  • ...14 more annotations...
  • She and others emphasized the apparent lack of severe health repercussions from reinfection — and the lack of evidence that reinfection is common.
  • Nearly 4 percent of people who had a previous infection were reinfected, an almost identical rate to those with no history of infection.
  • “Basically, it’s saying vaccination actually needs to be better than natural immunity. But vaccination is better than natural immunity.”
  • The study backs up recent laboratory data from South African researchers analyzing blood plasma from recovered patients. Nearly half of the plasma samples had no detectable ability to block the variant from infecting cells in a laboratory dish
  • The good news is that vaccine trials from Johnson & Johnson and Novavax show that vaccines can work — even against the B.1.351 variant, and particularly in preventing severe illness.
  • Novavax did not provide a breakdown of mild, moderate and severe cases, but severe cases of covid-19 were rare in the trial, suggesting that reinfection is unlikely to send people to the hospital.
  • “It is not surprising to see reinfection in individuals who are convalescent. And it would not be surprising to see infection in people who are vaccinated, especially a few months out from vaccine,”
  • “The key is not whether people get reinfected, it’s whether they get sick enough to be hospitalized.
  • “If the data holds true, it means we will need to walk the public back on the idea of how close we are to the finish line for ending this pandemic.”
  • Projections created by data scientist Youyang Gu — whose pandemic models have been cited by the Centers for Disease Control and Prevention — suggest that about 65 percent of America’s population will reach immunity by June 1. But built into that 65 percent is roughly 20 percent having immunity from past infections only.
  • In a separate study, scientists at Rockefeller University in New York took blood plasma from people who had been vaccinated and found that vaccine-generated antibodies were largely able to block mutations found on the B.1.351 variant.
  • I think the fact that we … now have data from two vaccines indicating that we can prevent serious disease, even against the new variant, is hopeful,”
  • A future concern needing close monitoring is whether the reformulation of vaccines to keep up with the evolving virus could drive the virus to continue evolving.
  • There is also a concern that subpar immunity could allow new resistant variants to emerge. That possibility, Nussenzweig said, is one reason that people should get both doses of a vaccine, on time.
Javier E

Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds - The New Y... - 0 views

  • in people who survived Covid-19, immune cells that recognize the virus lie quiescent in the bone marrow for at least eight months after infection. A study by another team indicated that so-called memory B cells continue to mature and strengthen for at least a year after infection.
  • Based on those findings, researchers suggested that immunity might last for years, possibly a lifetime, in people who were infected with the coronavirus and later vaccinated.
  • But it was unclear whether vaccination alone might have a similarly long-lasting effect.
  • ...13 more annotations...
  • “Usually by four to six weeks, there’s not much left,” said Deepta Bhattacharya, an immunologist at the University of Arizona. But germinal centers stimulated by the mRNA vaccines are “still going, months into it, and not a lot of decline in most people.”
  • The broader the range and the longer these cells have to practice, the more likely they are to be able to thwart variants of the virus that may emerge.
  • “Everyone always focuses on the virus evolving — this is showing that the B cells are doing the same thing,” said Marion Pepper, an immunologist at the University of Washington in Seattle. “And it’s going to be protective against ongoing evolution of the virus, which is really encouraging.”
  • Dr. Ellebedy’s team found that 15 weeks after the first dose of vaccine, the germinal center was still highly active in all 14 of the participants, and that the number of memory cells that recognized the coronavirus had not declined.
  • “The fact that the reactions continued for almost four months after vaccination — that’s a very, very good sign,” Dr. Ellebedy said. Germinal centers typically peak one to two weeks after immunization, and then wane.
  • After an infection or a vaccination, a specialized structure called the germinal center forms in lymph nodes. This structure is an elite school of sorts for B cells — a boot camp where they become increasingly sophisticated and learn to recognize a diverse set of viral genetic sequences.
  • The results suggest that a vast majority of vaccinated people will be protected over the long term — at least, against the existing coronavirus variants
  • But older adults, people with weak immune systems and those who take drugs that suppress immunity may need boosters; people who survived Covid-19 and were later immunized may never need them at all.
  • In the absence of variants that sidestep immunity, in theory immunity could last a lifetime, experts said. But the virus is clearly evolving.
  • “Anything that would actually require a booster would be variant-based, not based on waning of immunity,” Dr. Bhattacharya said. “I just don’t see that happening.”
  • The good news: A booster vaccine will probably have the same effect as prior infection in immunized people, Dr. Ellebedy said. “If you give them another chance to engage, they will have a massive response,” he said, referring to memory B cells.
  • Dr. Ellebedy said the results also suggested that these signs of persistent immune reaction might be caused by mRNA vaccines alone, as opposed to those made by more traditional means, like Johnson & Johnson’s
  • But that is an unfair comparison, because the Johnson & Johnson vaccine is given as a single dose, Dr. Iwasaki said: “If the J & J had a booster, maybe it will induce this same kind of response.”
huffem4

Trump's "Chinese Virus" and What's at Stake in the Coronavirus's Name | The New Yorker - 1 views

  • In another part of the study, the researchers determined that defining vaccination in terms of contamination—“the seasonal flu vaccine involves injecting people with the seasonal flu virus”—increased prejudice in subjects concerned about disease, whereas defining it in terms of protection—“the seasonal flu vaccine protects people from the seasonal flu virus”—had no such effect. Initiatives that minimize disease, the researchers concluded, might also end up minimizing discrimination.
  • It was only a matter of time before Donald Trump enlisted such language to serve his nativist agenda. Although COVID-19, the disease caused by the novel coronavirus, has killed more than twenty thousand people and affected countries around the world, Trump’s fixation on its origins in Wuhan, China, has encouraged a rash of anti-Asian bigotry in the United States.
  • This month, Trump has taken to referring to COVID-19 as the “Chinese virus,” presenting the label as a corrective to Beijing officials’ claims that the American military was the source of the outbreak.
  • ...6 more annotations...
  • Much of the old nomenclature has turned out to be not only stigmatizing but inaccurate. The Ebola virus, for instance, gets its name from a river that sits about forty miles from Yambuku, the Congolese village where researchers first investigated the disease, in 1976.
  • Still, it’s hard not to see a similarity between the recent reports of harassment against Asian-Americans and the stigmatization that gay people suffered in the wake of the AIDS outbreak.
  • Evolutionary psychologists refer to a “behavioral immune system” that attunes humans to physical differences or unfamiliar behavior, even when it poses no risk.
  • Last week, an Asian-American journalist reported that a member of the President’s staff called COVID-19 the “kung flu” to her face.
  • This may seem like a trivial issue to some, but disease names really do matter to the people who are directly affected
  • no disease better illustrates the perils of disease naming than AIDS, which, in its early days, was sometimes called “gay cancer.”
tongoscar

Coronavirus Live Updates: China Is Tracking Travelers From Hubei - The New York Times - 0 views

  • To combat the spread of the coronavirus, Chinese officials are using a combination of technology and policing to track movements of citizens who may have visited Hubei Province.
  • Mobile phone owners in China get their service from one of three state-run telecommunications firms, which this week introduced a feature for subscribers to send text messages to a hotline that generates a list of provinces they have recently visited. That has created a new way for the authorities to see where citizens have traveled.At a high-speed rail station in the eastern city of Yiwu on Tuesday, officials in hazmat suits demanded that passengers send the text messages and then show their location information to the authorities before being permitted to leave the station. Those who had passed through Hubei were unlikely to be allowed entry.
  • Top officials in Beijing on Thursday expanded their mass roundup of sick or possibly infected people beyond Wuhan, the city at the center of the outbreak, to include other cities in Hubei Province that have been hit hard by the crisis, according to the state-run CCTV broadcaster.
  • ...14 more annotations...
  • Chinese officials reported Friday that a surge in new infections was continuing, though not as markedly as the day before, when the number of people confirmed to have the virus in Hubei Province skyrocketed by 14,840 cases.
  • Japan has confirmed its first death from the virus.
  • For a moment on Thursday, it seemed as if there might be some good news from the Diamond Princess, the cruise ship being held in the port of Yokohama in Japan, when the authorities said they would release some passengers to shore to finish their quarantine.Instead, Japanese health officials announced the first death from the virus in the country, of a woman in her 80s. It was third death from the virus outside mainland China. The woman had no record of travel there.
  • The Centers for Disease Control said Thursday that a person under quarantine at a military base in San Antonio had tested positive for the virus, bringing the number of confirmed coronavirus patients in the United States to 15.
  • For the first time in a decade, global oil demand is expected to fall.
  • The arts world, too, is feeling the squeeze.Image
  • Movie releases have been canceled in China and symphony tours suspended. A major art fair in Hong Kong was called off. And spring art auctions half a world away in New York have been postponed because well-heeled Chinese buyers may find it difficult to travel to them.
  • The U.S. reported its 15th case after a person under quarantine tested positive.
  • The travel industry in Asia has been upended.Image
  • China ousted a provincial leader at the center of the outbreak.
  • China’s leader, Xi Jinping, on Thursday summarily fired two top Communist Party officials from Hubei Province, exacting political punishment for the regional government’s handling of the crisis.
  • A second citizen-journalist in Wuhan has disappeared.
  • A video blogger in the city of Wuhan who had been documenting conditions at overcrowded hospitals at the heart of the outbreak has disappeared, raising concerns among his supporters that he may have been detained by the authorities.The blogger, Fang Bin, is the second citizen journalist in the city to have gone missing in a week after criticizing the government’s response to the coronavirus epidemic.Mr. Fang began posting videos from hospitals in Wuhan on YouTube last month, including one that showed a pile of body bags in a minibus. In early February, Mr. Fang said he had been briefly detained and questioned. A few days later, he filmed an exchange he had with strangers who showed up at his apartment claiming to bring him food.Mr. Fang’s last video, posted on Sunday, was a message written on a piece of paper: “All citizens resist, hand power back to the people.”Last week, Chen Qiushi, a citizen-journalist and lawyer in Wuhan who recorded the plight of patients and the shortage of hospital supplies, vanished, according to his friends.
  • South Korea quarantined hundreds of soldiers who visited China.
tongoscar

What We Know Today about Coronavirus SARS-CoV-2 and Where Do We Go from Here - 0 views

  • The severe acute respiratory syndrome coronavirus SARS-CoV-2 (2019-nCoV) outbreak is an important reminder that the global community must strengthen national and international programs for early detection and response to future disease outbreaks.
  • Sequencing novel viruses helps remove the fear of the unknown by defining the viral genomic sequence for dissection and interpretation. While we are within the first two months of the first report to the World Health Organization (WHO) of SARS-CoV-21, and there remains much to learn, modern technology has identified and characterized the virus, sequenced its full genome, and started to describe the genetic evolution of the virus over a short time period.
  • Within less than 60 days of reporting, global scientists know the likely origin of the virus, how similar it is to related viruses that are better understood, and what therapies may be applicable.
  • ...5 more annotations...
  • As of February 7, over 80 SARS-CoV-2 genomes have been shared through the Global Initiative to Share All Influenza Data (GISAID) and GenBank, which will catalyze the research to understanding of the origin of the new virus, the epidemiology and transmission routes, and facilitate development of diagnostic and treatment strategies.3 Understanding the genome of SARS-CoV-2 early, provided unprecedented insight into dynamics of viral spread and impacted response strategies.
  • On January 24, the first SARS-CoV-2 genome was published in the New England Journal of Medicine.2 To our knowledge, this is the first time a complete genome of a novel infectious agent has been publicly available in such a short time after the first case was reported to the WHO.
  • Analysis of the genomic information currently available, indicates SARS-CoV-2 is most closely related to a known bat SARS-like Coronavirus, indicating bats as the likely origin.
  • While this is early in the outbreak, there are no specific drugs available to treat SARS-CoV-2. There is high sequence conservation between SARS-CoV-2 and related SARS-CoV in viral drug targets, such as in protease and polymerase enzymes.
  • Reports from Africa indicate no positive cases of SARS-CoV-2 thus far. However, the lack of confirmed diagnoses may be due to a limited capacity for in-country testing rather than the true epidemiology of the virus.
anniina03

Coronavirus: Why some countries wear face masks and others don't - BBC News - 0 views

  • Since the start of the coronavirus outbreak some places have fully embraced wearing face masks, and anyone caught without one risks becoming a social pariah.But in many other parts of the world, from the UK and the US to Sydney and Singapore, it's still perfectly acceptable to walk around bare-faced.
  • the official advice from the World Health Organization has been clear. Only two types of people should wear masks: those who are sick and show symptoms, and those who are caring for people who are suspected to have the coronavirus.
  • a mask is not seen as reliable protection, given that current research shows the virus is spread by droplets and contact with contaminated surfaces. So it could protect you, but only in certain situations such as when you're in close quarters with others where someone infected might sneeze or cough near your face.
  • ...10 more annotations...
  • Removing a mask requires special attention to avoid hand contamination, and it could also breed a false sense of security.
  • in some parts of Asia everyone now wears a mask by default - it is seen as safer and more considerate.
  • In mainland China, Hong Kong, Japan, Thailand and Taiwan, the broad assumption is that anyone could be a carrier of the virus, even healthy people. So in the spirit of solidarity, you need to protect others from yourself.
  • In East Asia, many people are used to wearing masks when they are sick or when it's hayfever season, because it's considered impolite to be sneezing or coughing openly.
  • The 2003 Sars virus outbreak, which affected several countries in the region, also drove home the importance of wearing masks, particularly in Hong Kong, where many died as a result of the virus.So one key difference between these societies and Western ones, is that they have experienced contagion before - and the memories are still fresh and painful.
  • Some argue that ubiquitous mask wearing, as a very visual reminder of the dangers of the virus, could actually act as a "behavioural nudge" to you and others for overall better personal hygiene.
  • But there are downsides of course. Some places such as Japan, Indonesia and Thailand are facing shortages at the moment, and South Korea has had to ration out masks.
  • There is the fear that people may end up re-using masks - which is unhygienic - use masks sold on the black market, or wear homemade masks, which could be of inferior quality and essentially useless.
  • People who do not wear masks in these places have also been stigmatised, to the point that they are shunned and blocked from shops and buildings.
  • In countries where mask wearing is not the norm, such as the West, those who do wear masks have been shunned or even attacked. It hasn't helped that many of these mask wearers are Asians.
Javier E

COVID-19: Individually Rational, Collectively Disastrous - The Atlantic - 0 views

  • One major problem is that stopping the virus from spreading requires us to override our basic intuitions.
  • Three cognitive biases make it hard for us to avoid actions that put us in great collective danger.
  • 1. Misleading Feedback
  • ...14 more annotations...
  • some activities, including dangerous ones, provide negative feedback only rarely. When I am in a rush, I often cross the street at a red light. I understand intellectually that this is stupid, but I’ve never once seen evidence of my stupidity.
  • Exposure to COVID-19 works the same way. Every time you engage in a risky activity—like meeting up with your friends indoors—the world is likely to send you a signal that you made the right choice. I saw my pal and didn’t get sick. Clearly, I shouldn’t have worried so much about socializing!
  • Let’s assume, for example, that going to a large indoor gathering gives you a one in 20 chance of contracting COVID-19—a significant risk. Most likely, you’ll get away with it the first time. You’ll then infer that taking part in such gatherings is pretty safe, and will do so again. Eventually, you are highly likely to fall sick.
  • 2. Individually Rational, Collectively DisastrousWe tend to think behavior that is justifiable on the individual level is also justifiable on the collective level, and vice versa. If eating the occasional sugary treat is fine for me it’s fine for all of us. And if smoking indoors is bad for me, it’s bad for all of us.
  • The dynamics of contagion in a pandemic do not work like that
  • if everyone who isn’t at especially high risk held similar dinner parties, some percentage of these events would lead to additional infections. And because each newly infected person might spread the virus to others, everyone’s decision to hold a one-off dinner party would quickly lead to a significant spike in transmissions.
  • The dynamic here is reminiscent of classic collective-action problems. If you go to one dinner, you’ll likely be fine. But if everyone goes to one dinner, the virus will spread with such speed that your own chances of contracting COVID-19 will also rise precipitously.
  • 3. Dangers Are Hard to Recognize and Avoid
  • Many of the dangers we face in life are easy to spot—and we have, over many millennia, developed biological instincts and social conventions to avoid them
  • When we deal with an unaccustomed danger, such as a new airborne virus, we can’t rely on any of these protective mechanisms.
  • The virus is invisible. This makes it hard to spot or anticipate. We don’t see little viral particles floating through the air
  • In time, we can overcome these biases (at least to some extent).
  • Social disapprobation can help
  • We all should do what we can to identify the biases from which we suffer—and try to stop them from influencing our behavior.
Javier E

Coronavirus Treatment: Hundreds of Scientists Scramble to Find One - The New York Times - 0 views

  • Working at a breakneck pace, a team of hundreds of scientists has identified 50 drugs that may be effective treatments for people infected with the coronavirus.
  • Many of the candidate drugs are already approved to treat diseases, such as cancer, that would seem to have nothing to do with Covid-19, the illness caused by the coronavirus.
  • If the research effort succeeds, it will be a significant scientific achievement: an antiviral identified in just months to treat a virus that no one knew existed until January.
  • ...12 more annotations...
  • Dr. Krogan and his colleagues set about finding proteins in our cells that the coronavirus uses to grow. Normally, such a project might take two years. But the working group, which includes 22 laboratories, completed it in a few weeks.
  • In 2011, Dr. Krogan and his colleagues developed a way to find all the human proteins that viruses use to manipulate our cells — a “map,” as Dr. Krogan calls it. They created their first map for H.I.V.
  • That virus has 18 genes, each of which encodes a protein. The scientists eventually found that H.I.V. interacts, in one way or another, with 435 proteins in a human cell.
  • In February, the research group synthesized genes from the coronavirus and injected them into cells. They uncovered over 400 human proteins that the virus seems to rely on.
  • The flulike symptoms observed in infected people are the result of the coronavirus attacking cells in the respiratory tract.
  • The new map shows that the virus’s proteins travel throughout the human cell, engaging even with proteins that do not seem to have anything to do with making new viruses.
  • Kevan Shokat, a chemist at U.C.S.F., is poring through 20,000 drugs approved by the Food and Drug Administration for signs that they may interact with the proteins on the map created by Dr. Krogan’s lab.
  • If promising drugs are found, investigators plan to try them in an animal infected with the coronavirus — perhaps ferrets, because they’re known to get SARS, an illness closely related to Covid-19.
  • Even if some of these drugs are effective treatments, scientists will still need to make sure they are safe for treating Covid-19. It may turn out, for example, that the dose needed to clear the virus from the body might also lead to dangerous side effects.
  • In past studies on animals, remdesivir blocked a number of viruses. The drug works by preventing viruses from building new genes.
  • In February, a team of researchers found that remdesivir could eliminate the coronavirus from infected cells. Since then, five clinical trials have begun to see if the drug will be safe and effective against Covid-19 in people.
  • Other researchers have taken startling new approaches. On Saturday, Stanford University researchers reported using the gene-editing technology Crispr to destroy coronavirus genes in infected cells.
tongoscar

U.S. prepares for coronavirus pandemic, school and business closures: health officials ... - 0 views

  • The United States has yet to see community spread of the virus that emerged in central China in late December. But health authorities are preparing medical personnel for the risk, Nancy Messonnier, an official with the Centers for Disease Control and Prevention (CDC) told reporters on a conference call.
  • “We’re not seeing community spread here in the United States yet, but it’s very possible, even likely, that it may eventually happen,” Messonnier said.
  • “Our goal continues to be to slow the introduction of the virus into the U.S. This buys us more time to prepare communities for more cases and possibly sustained spread.”
  • ...3 more annotations...
  • The World Health Organization has warned that the window of opportunity to contain the international spread of the epidemic that has killed more than 2,200 people was closing, as the virus has spread to some 26 countries with a large cluster in South Korea and recent outbreaks in Iran, Lebanon and Italy
  • “If we do well, we can avert any serious crisis, but if we squander the opportunity then we will have a serious problem on our hands,” WHO chief Tedros Adhanom Ghebreyesus said in Geneva.
  • The United States currently has 13 cases of people diagnosed with the virus within the country and 21 cases among Americans repatriated on evacuation flights from Wuhan, China, and from the Diamond Princess cruise ship in Japan, CDC said.
tongoscar

What scientists know so far about the effects of coronavirus on children | Jonathan Bal... - 0 views

  • These were the groups initially urged to socially distance themselves. But we’re beginning to see that coronavirus can make some younger people seriously ill.
  • Compared to other European countries, the UK was slow in closing schools – waiting until there had already been 104 deaths due to coronavirus to take action. Studies from China showed children were rarely diagnosed with novel coronavirus, and therefore presumably had little role in the spread of the disease.
  • Like many of my colleagues, I could see no obvious reason why children weren’t being infected: this was a virus spread by the respiratory route, not through a process unique to adults. If significant numbers of children were infected and suffered very minor cold-like symptoms, then their potential to spread the virus was immense.
  • ...2 more annotations...
  • The current coronavirus is different. In more than 85% of confirmed cases symptoms can go undetected or be easily confused with the common cold of mild flu. Its biggest weapon – the thing that has, according to one study, allowed it to spread so easily – is this ability to cause mild disease in the majority of people it infects. When you can’t easily tell if someone has a cold or coronavirus, case identification and infection control are far more difficult.
  • Judging from past pandemics, school closures can be an effective way to reduce the spread of a virus – particularly when they form part of a larger programme of social distancing measures. Every school day, children congregate en masse, often in close proximity, and then return home, taking with them any new infection they’ve picked up. Intuitively, reducing this cycle should help slow the virus.
Javier E

No, a Negative Coronavirus Test Does Not Mean You Can Safely Socialize - The New York T... - 0 views

  • he main reason is that a test gives information about the level of the virus at one point in time. A person could be infected but not have enough virus yet for it to register on a test. Or, a person may become infected in the hours or days after taking a test. Also, the tests do not have 100 percent accuracy.
  • A test “filters out those who are positive and definitely shouldn’t be there,” she said. “Testing negative basically changes nothing about behavior. It still means wear a mask, distance, avoid indoors if you can.”
  • Taking multiple tests over a period of days gives a clearer answer. But experts cautioned that no test — regardless of how many times it’s taken in succession — can definitively determine whether someone infected by the coronavirus is contagious, or no longer poses a transmission risk to other people.
  • ...5 more annotations...
  • a full 64 percent said that even if they tested negative, they would not be comfortable spending time indoors with people they don’t live with.
  • In an informal survey of 670 epidemiologists, just 6 percent said that if they recently tested negative for the virus, they would be comfortable spending time indoors with others without precautions
  • “The risk that you have, if everyone is tested before you get together to sit down for dinner, dramatically decreases. It might not ever be zero but, you know, we don’t live in a completely risk-free society.”
  • Before gathering with others, Dr. Mina said, people could combine a negative test with a two-week quarantine if they’re able
  • Avoiding any contact with other people for a week or more before taking a test is a powerful tool, said Jeffrey Townsend, a professor of biostatistics at the Yale School of Public Health. Not only does it decrease exposure, but it also gives the virus more opportunity to reach detectable levels in infected people, his research has found.
1 - 20 of 148 Next › Last »
Showing 20 items per page